Aurobindo to resume production at aseptic lines of Eugia Pharma's Unit-III

Aurobindo Pharma plans to resume commercial production at Eugia Pharma's Pashamylaram formulations facility in Hyderabad. Distribution of aseptic products has restarted. World Health Organisation recommends Unit-IV of its wholly owned subsidiary APL Healthcare as a manufacturing site for Dolutegravir, Lamivudine, Tenofovir...